Biomarker based adaptive development in Alzheimer (BioAdaptAD).

The general objectives of this project are to develop a BACE inhibitor for disease modification in Alzheimer's disease and to explore the development in an earlier prodromal Alzheimer's disease population. From a drug development perspective, this will involve multiple adaptation steps and the intensive use of biomarkers.

Keywords:NEURODEGENERATIVE BRAIN DISEASES, ALZHEIMER'S DISEASE, BIOMARKER

Disciplines:Genetics, Systems biology, Multimedia processing, Biological system engineering, Signal processing, Molecular and cell biology

Project type:Collaboration project